Sleep medicine physician, 12 years of clinical experience. I prescribe modafinil regularly for narcolepsy, idiopathic hypersomnia, and shift work sleep disorder. I am happy to answer questions within appropriate limits — I cannot give personal medical advice, but I can speak to general clinical practice.
A few things I want to address upfront that I see discussed incorrectly online:
1. “Modafinil is basically like having a superpower”: From a clinical standpoint, modafinil restores function for people with genuine wakefulness disorders. For healthy users without a disorder, the effect is more modest than forum hype suggests. It is a useful tool, not a superpower.
2. “It has no addiction potential”: The abuse/addiction potential is meaningfully lower than amphetamines. It is not zero. Psychological dependence — the feeling that you cannot function without it — occurs in a subset of users. This is worth taking seriously.
3. “Long-term safety is proven”: Long-term safety data exists primarily in patient populations. Safety in healthy individuals using it off-label long-term is less well-studied. I encourage caution and periodic breaks.
What questions do you have?
What is your view on indefinite long-term use in patients with genuine chronic conditions like narcolepsy?
For true narcolepsy with orexin deficiency, indefinite use is often appropriate and necessary. The alternative — untreated narcolepsy — has significant quality of life and safety implications (driving, occupational safety). The risk-benefit analysis is clearly favourable for diagnosed patients.
Do you see many patients who develop psychological dependence, and what does that look like clinically?
Occasionally. It presents as increasing dose escalation to maintain effect, using modafinil to avoid dealing with underlying fatigue causes (sleep disorder, depression, burnout), and significant anxiety on days when it is unavailable. In these cases I work on the underlying cause rather than just adjusting the modafinil dose.
What do you consider the most underappreciated risk for people using it without medical supervision?
The cardiovascular risk in people with undiagnosed hypertension or arrhythmia. Modafinil can unmask these conditions. Anyone over 40 without a recent cardiovascular check-up should get one before starting.
Thank you for contributing to this forum. Question: in clinical practice, what is your approach when a patient asks about modafinil for cognitive enhancement rather than a diagnosed condition?
I have had this conversation many times. I explain the evidence honestly — modest effects in non-sleep-deprived healthy adults — and discuss the risk/benefit. I do not prescribe it for enhancement in healthy patients. I try to understand the underlying issue: is it poor sleep, undiagnosed ADHD, depression, or lifestyle factors? Those have better solutions.
How do you respond to patients who report that their prescribed dose has become less effective over time?
First I investigate whether the dose is truly insufficient or whether expectations have increased. If genuine tolerance is suspected, a dose holiday of 2–4 weeks often fully restores effect. True pharmacological tolerance requiring dose escalation is uncommon in my experience.